INVO BioScience, Inc. (IVOB) financial statements (2021 and earlier)

Company profile

Business Address 5582 BROADCAST COURT
SARASOTA, FL 34240
State of Incorp. NV
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1,23921226152492
Cash and cash equivalents1,23921226152492
Receivables82268731
Inventory, net of allowances, customer advances and progress billings10144598565
Inventory10144598565
Prepaid expense 2496311 
Other undisclosed current assets196    
Total current assets:1,543731234251559
Noncurrent Assets
Property, plant and equipment93341616 
Other noncurrent assets15912161921
Total noncurrent assets:25246323521
TOTAL ASSETS:1,795777266286580
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities7653,0874,9164,5514,116
Accounts payable3725729619751,026
Employee-related liabilities3932,5153,9553,5763,090
Taxes payable1    
Deferred revenue714
Debt21132 1010
Due to related parties 9211211211
Contract with customer, liability19
Other undisclosed current liabilities 255   
Total current liabilities:1,5013,5025,1274,7724,337
Noncurrent Liabilities
Long-term debt and lease obligation407 132132 
Long-term debt, excluding current maturities326 132132 
Operating lease, liability81
Liabilities, other than long-term debt3,600    
Deferred revenue3,571
Due to related parties29    
Other undisclosed noncurrent liabilities0    
Total noncurrent liabilities:4,008 132132 
Total liabilities:5,5093,5025,2594,9044,337
Stockholders' equity
Stockholders' equity attributable to parent(3,714)(2,724)(4,992)(4,618)(3,757)
Common stock1615141414
Additional paid in capital20,16018,98213,63913,31112,048
Accumulated deficit(23,889)(21,721)(18,645)(17,943)(15,819)
Total stockholders' equity:(3,714)(2,724)(4,992)(4,618)(3,757)
TOTAL LIABILITIES AND EQUITY:1,795777266286580

Income statement (P&L) ($ in thousands)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues1,4804942825112
Cost of revenue(140)(90)(52)(15)(8)
Cost of goods and services sold  (52)(15)(8)
Gross profit:1,341404230364
Operating expenses(3,129)(3,038)(871)(2,146)(599)
Operating loss:(1,788)(2,634)(640)(2,110)(595)
Nonoperating expense(379)(442)(62)(14) 
Debt instrument, convertible, beneficial conversion feature 895   
Other nonoperating expense  (62)(14) 
Interest and debt expense(94)(442)(41)(14)(4,332)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes944424114(32)
Loss from continuing operations before income taxes:(2,167)(3,076)(702)(2,124)(4,959)
Income tax expense(0) (1,680)  
Net loss:(2,168)(3,076)(2,382)(2,124)(4,959)
Other undisclosed net income attributable to parent  1,680  
Net loss available to common stockholders, diluted:(2,168)(3,076)(702)(2,124)(4,959)

Comprehensive Income ($ in thousands)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(2,168)(3,076)(2,382)(2,124)(4,959)
Comprehensive loss, net of tax, attributable to parent:(2,168)(3,076)(2,382)(2,124)(4,959)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: